Remove Compliance Remove DEA Remove Legalization
article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 191
article thumbnail

FDA Approves CBD-Containing Drug - Will the DEA Finally Step Up?

MJ Business Attorneys

Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. In the recent case Hemp Industries Associations v.

DEA 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Aurum Labs Receives CDPHE Certification and is Poised to be the First DEA Registered Cannabis & Hemp Testing Laboratory in the US

Cannabis Law Report

Aurum Labs ( [link] ) is now certified by the Colorado Department of Public Health and Environment (CDPHE) to conduct hemp compliance testing for manufactured industrial hemp products and is in the final stages of Drug Enforcement Agency (DEA) registration.

DEA 98
article thumbnail

From DEA to Legal Cannabis: Charles Feldmann Weighs In

CannaTech

As a Marine Corps federal prosecutor, DEA Drug Task Force Commander and state narcotics prosecutor, Charles spent many years engaged in the War on Drugs. CannaTech alumnus sponsor and cannabis legal expert. A Former DEA Prosecutor’s Journey into the Global Cannabis Industry. Charles Feldmann, Esq. Big weed earned my trust.

DEA 80
article thumbnail

Segra International Completes First Export of Cannabis Plantlets From Canada To USA

Cannabis Law Report

In recent months, the DEA has issued a select number of licenses to several groups in the US to allow for the cultivation of Cannabis for scientific research purposes. Under the federal licensing regime, BRC is only allowed to source genetics and starting material from DEA-compliant or federally legal sources.

article thumbnail

CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health

Cannabis Law Report

(OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research Company , (BRC), an active Drug Enforcement Administration (DEA) license holder, to produce federally-compliant cannabis-based medical products.

article thumbnail

Charles Feldmann to Speak at Canna Tech Global

MJ Business Attorneys

Charles Feldmann, a former DEA Drug Task Force Commander and former state’s narcotics prosecutor, will be sharing his insight and expertise on the other side of the cannabis constitutional law. Mr. Feldmann’s talk is titled, “The United States Federal Government and the Cannabis Industry.

DEA 100